Cases 1, 6, 7, 8, and 10 were initially treated with SSA and had a mild decrease in their GH/IGF-1 levels compared to before, as well as thyroid function showing improvement in hyperthyroidism. The gene discussed is GH1; the disease is hyperthyroidism.